Rob Aboud
Consigliere Generale presso Affinia Therapeutics, Inc.
Posizioni attive di Rob Aboud
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Consigliere Generale | 01/08/2019 | - |
Storia della carriera di Rob Aboud
Precedenti posizioni note di Rob Aboud
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Faber Daeufer Itrato & Cabot PC
 Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Corporate Officer/Principal | 01/11/2013 | 01/08/2019 |
Formazione di Rob Aboud
| Albright College | Undergraduate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Temple University (Pennsylvania) | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Graduate Degree | 2 |
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Affinia Therapeutics, Inc. is a preclinical stage company, which engages in the research and development of gene therapy. It offers Affinia Rationally-designed Therapies (ART) platform, which develops novel therapies, focusing on the key components of a gene therapy: capsids, which are the outer shells of a virus used to package the genetic code to treat a disease; promoters, which control how the cells read the genetic code that is delivered; and manufacturing approaches, which determine the quality and cost of potential medicines. The company was founded by Luk Vandenberghe, Botond Roska, and Aaron Tward in 2019 and is headquartered in Waltham, MA. | Health Technology |
Faber Daeufer Itrato & Cabot PC
Faber Daeufer Itrato & Cabot PC Miscellaneous Commercial ServicesCommercial Services Faber Daeufer Itrato & Cabot PC is an American company that provides legal services. | Commercial Services |
- Borsa valori
- Insiders
- Rob Aboud
- Esperienza
